Literature DB >> 31686741

Case Control Study to Compare Serum Vascular Endothelial Growth Factor (VEGF) Level in Women with Recurrent Pregnancy Loss (RPL) Compared to Women with Term Pregnancy.

Pallavi Gupta1, Sujata Deo1, S P Jaiswar1, P L Sankhwar1.   

Abstract

INTRODUCTION: Recurrent pregnancy loss (RPL) is defined as three or more spontaneous pregnancy losses before the 20th week of gestation or fetal weight of < 500 gm from the last menstrual period. Vascular endothelial growth factor (VEGF) is essential for implantation, development of embryo and placental angiogenesis. Women with low VEGF level are believed to be at higher risk of RPL.
OBJECTIVE: To measure the level of VEGF in women with RPL and compare it with women with 1 or more successful pregnancies.
METHODS: This is a Case control study carried out in King George Medical University, Lucknow from August 2015 to 2016. Participants sample size was 60 women. Thirty women with 3 or more spontaneous abortions were included as cases, and 30 women with at least 1 successful term pregnancy were controls. Serum VEGF level was analyzed using ELISA kit. Main outcome measured: 1. Serum VEGF level in the two groups. 2. Serum VEGF level in different underlying etiologies in women with RPL.
RESULTS: Mean VEGF level was 105.3 pg/mL in RPL cases, while it was 156.8 pg/mL in fertile controls. (p = 0.01). VEGF level was 86.2 pg/mL in patients with anatomical defects, 109 pg/mL in APLA syndrome, 85.1 pg/mL in hypothyroidism and 122.2 pg/mL in unexplained RPL.
CONCLUSION: The mean serum VEGF level was significantly lower in women with recurrent pregnancy loss compared with women with successful term pregnancy, implicating its role in maintaining pregnancy. © Federation of Obstetric & Gynecological Societies of India 2018.

Entities:  

Keywords:  Antiphospholipid syndrome; Recurrent pregnancy loss; Vascular endothelial growth factor (VEGF)

Year:  2018        PMID: 31686741      PMCID: PMC6801282          DOI: 10.1007/s13224-018-1097-5

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  5 in total

1.  Recurrent pregnancy loss: etiology, diagnosis, and therapy.

Authors:  Holly B Ford; Danny J Schust
Journal:  Rev Obstet Gynecol       Date:  2009

2.  Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?

Authors:  P Egerup; A M Kolte; E C Larsen; M Krog; H S Nielsen; O B Christiansen
Journal:  Hum Reprod       Date:  2016-09-02       Impact factor: 6.918

3.  Effect of the functional VEGFA-583C/T variant on vascular endothelial growth factor levels and the risk of recurrent spontaneous miscarriage.

Authors:  Ghada M Al-Khateeb; Fekriya E Mustafa; Mai S Sater; Wassim Y Almawi
Journal:  Fertil Steril       Date:  2011-04-02       Impact factor: 7.329

4.  Vascular endothelial growth factor gene polymorphism and implantation failure.

Authors:  Cammi Goodman; R S Jeyendran; C B Coulam
Journal:  Reprod Biomed Online       Date:  2008-05       Impact factor: 3.828

5.  Gene expression analysis of VEGF and its receptors and assessment of its serum level in unexplained recurrent spontaneous abortion.

Authors:  Elham Amirchaghmaghi; Abbas Rezaei; Ashraf Moini; Mohammad Ali Roghaei; Maryam Hafezi; Reza Aflatoonian
Journal:  Cell J       Date:  2015-01-13       Impact factor: 2.479

  5 in total
  2 in total

1.  Differences in the Expression of KIR, ILT Inhibitory Receptors, and VEGF Production in the Induced Decidual NK Cell Cultures of Fertile and RPL Women.

Authors:  Monika Kniotek; Aleksander Roszczyk; Michał Zych; Monika Szafarowska; Małgorzata Jerzak
Journal:  Biomed Res Int       Date:  2021-05-04       Impact factor: 3.411

Review 2.  miRNAs in decidual NK cells: regulators worthy of attention during pregnancy.

Authors:  Liman Li; Ting Feng; Weijie Zhou; Yuan Liu; Hong Li
Journal:  Reprod Biol Endocrinol       Date:  2021-10-02       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.